<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>

Clinical Hold on 3 CARsgen CAR T-cell Therapies 12/14/2023

Stakeholder Technical Issues with Ophthalmic Guide 12/14/2023

FDA Approves Neuroblastoma Drug 12/14/2023

Update GAO Device Recall Oversight Report: Senators 12/13/2023

Novid Distributing Unapproved, Misbranded Drug: FDA 12/13/2023

Guide on Advanced Manufacturing Tech 12/13/2023

Regulatory Affairs, Foods Program Under Review 12/13/2023

HELP Committee OKs EFFECTIVE Opioid Bill 12/13/2023

GOP Senators Urge Increase in Foreign Inspections 12/13/2023

Amgen Files Priority BLA for Lung Cancer 12/13/2023

AdvaMed Faults FDA on ‘Safety’ 510(k) Guidances 12/13/2023

Supreme Court Agrees to Hear Mifepristone Case 12/13/2023

New Genetic Metabolic Disease Treatment A/C 12/12/2023

Strengthen Botox Safety Warning: Public Citizen 12/12/2023

Advanced Manufacturing Technologies Guidance 12/12/2023

Dolor Tech Settles Over Migraine Device 12/12/2023

Peptide Clinical Pharmacology Guidance 12/12/2023

Risk-Based Approach to Therapeutic Protein DDI 12/12/2023

CDISC Study Tabulation Model Version 3.4 12/12/2023

FDA May Not be Ready for LDT Rule: Attorney 12/12/2023

Oncology Drug Dose Optimization Often Deferred: Analysis 12/12/2023

First Psychedelic NDA Filing Claimed for PTSD Therapy 12/12/2023

Trump Aligned Group Sues FDA on Ivermectin 12/11/2023

Guide on DTC Quantitative Efficacy/Risk Info 12/11/2023

Device CEO Pleads Guilty in Covid Test Scheme 12/11/2023

FDA Requiring Less Burdensome Isotretinoin REMS 12/11/2023

NDA Resubmission on Hypoparathyroidism Accepted 12/11/2023

PETA Letter Hits at FDA Lab Animal 'Cruelty' 12/11/2023

Pfizer BLA for Hemophilia Accepted for Review 12/11/2023

First Sickel Cell Gene Therapies Approved 12/08/2023

Novartis Reports Risk Reduction Kisqali Data 12/08/2023

Guide on Drug Supply Chain Security 12/08/2023

Getinge Recalls CardioHelp Emergency Drive 12/08/2023

Info Collection on OTC Drugs 12/08/2023

Cardinal Health Recalls Procedure Kits 12/08/2023

Section 503B Compounding Enforcement Discretion 12/07/2023

FDA Clears BD ‘Novel’ Blood Sampler 12/07/2023

Bill to Establish HHS Generic Drug Manufacturer 12/07/2023

Alpha Cognition NDA for Alzheimer’s Filed 12/07/2023

Positive Phase 1/2 Linvoseltamab Results to FDA 12/07/2023

Pediatric Drug Development Bill Introduced 12/07/2023

Action Against BPI Methylene Blue Injection Asked 12/07/2023

Restrict ANDAs for Generic Xipere: Bausch & Lomb 12/07/2023

Merck Halts Keytruda Lung Cancer Trial 12/07/2023

Pro Publica Slams FDA on Respirator Recall 12/07/2023

FDA Sets Bulk Substance Compounding Policy 12/06/2023

FDA Grants, Denies Provepharm ProvayBlue Petition 12/06/2023

Novartis’ Fabhalta for PNH Approved 12/06/2023

Probe FDA ‘Cozy Relationship’ with Pharma: Rep. Harris 12/06/2023

Restrict ANDAs for Generic Zoryve: Arcutis 12/06/2023

eSTAR e-Submissions Open for PMAs 12/06/2023

CBER Helping to Speed Gene Therapies: Marks 12/06/2023

Opdivo sBLA for Bladder Cancer 12/06/2023

Animal Drug Regulations Amended 12/06/2023

Industry Concerns with Predicate Device Guide 12/06/2023

Review Extended on Sinus Drug 12/06/2023

Oncology Center Pact on Real-world Evidence 12/05/2023

Belmont Eyecare Selling Unapproved Eye Drops: FDA 12/05/2023

MONARCH 3 Results Show Verzenio Success: Lilly 12/05/2023

How FDA ‘One-stop’ PJOs Help Combo Industry 12/05/2023

No Safety Issues in Biosimilar Switches: CDER Research 12/05/2023

Pentagon Hits FDA on Generic Testing 12/05/2023

FDA Releases Novartis Untitled Letter on GMPs 12/05/2023

ABK Biomedical Gets Breakthrough Status 12/05/2023

FDA Urges ClinicalTrials.gov Compliance 12/04/2023

Lilly’s Jaypirca Gains OK in Leukemia/Lymphoma 12/04/2023

Pressing Need for Alternative Inspections: Researchers 12/04/2023

J&J Breakthrough Status on Bladder Cancer Drug 12/04/2023

Lawmakers Press Califf on OTC Decongestant 12/04/2023

West Pharma Vial2Bag Admixture Device Cleared 12/04/2023

CDER Cleaning House on Dormant Petitions 12/01/2023

Eitan Medical Recall Infusion Pumps 12/01/2023

Info Collection Extension on Orphan Drugs 12/01/2023

Twice-Daily Weight Loss Drug Stalls: Pfizer 12/01/2023

Epcoritamab Breakthrough Status in Follicular Lymphoma 12/01/2023

BD Recalls Pumps Over Syringe Incompatibility 12/01/2023

FDA Checking Chinese Syringe Safety 11/30/2023

Chief Scientist Tapped as Woodcock Replacement 11/30/2023

More Novo Nordisk Semaglutide Legal Actions 11/30/2023

AbbVie Seeks Accelerated OK for Lung Cancer Drug 11/30/2023

UCB on Pregnancy Safety Studies 11/30/2023

FDA Clears GE Critical Care Suite 2.1 11/30/2023

FDA Fast Track for eFFECTOR’s Zotatifin 11/30/2023

AdvaMed Comments on Electronic Submission Guide 11/29/2023

Concerns About FDA QMM Program 11/29/2023

Durbin, Grassley Push Drug Ad Transparency Bill 11/29/2023

FDA Opens Drug Supply Chain Security Act Portal 11/29/2023

FDA Denies Apixaban ANDA Petition for Safety 11/29/2023

SCA Pharma Issued 10-Item FDA-483 11/29/2023

Karuna NDA for Schizophrenia Accepted by FDA 11/29/2023

Praise for Graft-Versus-Host Drug Guidance 11/29/2023

FDA Studies Nasal Spray Distribution 11/29/2023

FDA Still Evaluating Left Atrial Occlusion Implants 11/29/2023

New Theories of False Claims Act Liability 11/29/2023

Regenerative Medicine Consensus Standards Guide 11/28/2023

‘Similar’ Intas CGMP Violations 11/28/2023

Korsuva Regulatory Review Period 11/28/2023

Cosela Regulatory Review Period 11/28/2023

Serious Reaction to Some Anti-Seizure Meds: FDA 11/28/2023

Acelyrin Auditing Izokibep Trial Issues 11/28/2023

<< Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>